GET DAILY SIGNALSUiPath (PATH) Stock Slips -34% in a Month as Growth Outlook Weighs on Sentiment
Key Takeaways
- UiPath shares declined roughly 34% over the trailing 30 days, from a closing price of $18.67 on August 31 to $12.32 as of the September 29 close.
- The selloff began after the company's fiscal Q2 2027 results on September 3, which topped revenue estimates but guided to a notable slowdown in third-quarter growth.
- A series of analyst downgrades and price-target cuts followed the earnings report and a September 22 investor day, reinforcing negative sentiment.
- Despite the recent drop, the stock remains up about 13% over the trailing three months, reflecting a sharp July–August rally that has since largely unwound.
- Competition from AI-native platforms and customer pushback on UiPath's AI pricing remain key overhangs on the stock.
UiPath (PATH) Company Snapshot and Competitive Landscape
UiPath, Inc. focuses on enterprise automation and AI software, with its roots in robotic process automation. The platform blends reliable automation with AI-driven agentic features, allowing companies to streamline processes in areas like finance, customer service, healthcare, and supply chains. Its offerings include core automation tools, the UiPath Platform, and newer AI solutions designed for more intricate, AI-heavy workflows.
Led by CEO Daniel Dines, PATH operates in a rapidly evolving space where established players such as Microsoft, Salesforce, and ServiceNow are integrating their own AI agents into established products. I follow PATH because of its position in the AI-automation narrative, its subscription revenue base, and ongoing questions about how much an independent orchestration layer can deliver as AI spreads more widely. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
PATH Stock Moves Over the Past 30 Days and Quarter
In the last 30 days, PATH dropped approximately 34%, moving from a close of $18.67 on August 31 to $12.32 on September 29. Most of the decline hit early in September, with a roughly 16.6% single-day drop right after earnings, and it continued through late September following the investor day that did not introduce new financial targets.
Looking back three months to June 30, when the stock closed at $10.87, PATH is still ahead by about 13% for the quarter overall. The period featured a strong July–August advance fueled by AI-related enthusiasm and a solid fiscal Q1 report, but September’s reversal wiped out most of those earlier gains. From what I see, this contrast highlights how quickly sentiment can shift in the sector.
Factors Behind the Recent 30-Day Decline
The main trigger was UiPath’s fiscal Q2 2027 earnings, released after the close on September 3. Revenue came in at $410.3 million, a 13.4% year-over-year increase that beat estimates around $398 million, while non-GAAP EPS of $0.15 matched expectations. Annual recurring revenue grew about 12% to $1.94 billion.
Guidance drew the most attention, however. The third-quarter revenue range of $440 million to $445 million pointed to growth slowing to roughly 8% year over year. Billings also missed slightly, and management noted longer sales cycles as customers evaluate deterministic versus AI-driven automation. The stock fell about 16.6% the next day. I’m watching this closely because further analyst actions added pressure, with Canaccord Genuity moving to Hold and several others, including UBS, Barclays, RBC, Truist, and BMO, lowering targets. After the September 22 investor day, which emphasized AI orchestration without new fiscal 2028 numbers, additional cuts and a downgrade to Underperform from DA Davidson weighed on the shares. Competition and pricing concerns on the AI side played a role as well.
Quarterly Performance Drivers
The quarter reflected two distinct phases. July and August brought a sharp rally, with the stock roughly doubling from late-June levels to near $18.67 by late August, as investors moved into AI-linked software names and reacted positively to fiscal Q1 results and improving profitability. Management’s comments on AI demand supported the move.
September reversed that momentum. Even with the revenue beat in Q2, the slower growth outlook and more cautious analyst commentary shifted the tone. Questions about sustaining expansion amid native AI integrations by larger vendors and customer resistance to pricing became more prominent. The result was a quarter that ended modestly higher but far from August peaks.
Key Areas to Monitor Going Forward
Attention will center on whether UiPath can regain momentum in ARR and show that its AI orchestration approach supports lasting revenue growth. The December earnings report will serve as an important checkpoint, especially with the CFO transition to Hitesh Ramani now in place.
Competitive dynamics, adoption of newer AI products, and the company’s ability to maintain pricing will remain central. Broader economic conditions, including interest rates and enterprise spending patterns, will also influence valuation given the stock’s sensitivity to growth expectations. These elements together are likely to shape the path ahead.
Using Tickeron’s AI Tools for Deeper Analysis
In my own research process, I often turn to Tickeron’s AI Daily Buy/Sell Signals to cross-check momentum indicators across similar names. The platform’s AI Trend Prediction Engine has also helped me evaluate longer-term patterns without relying solely on traditional metrics. These resources provide an additional layer of data when assessing how PATH fits into the wider automation and AI sector.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
Momentum Indicator for PATH turns positive, indicating new upward trend
PATH saw its Momentum Indicator move above the 0 level on October 20, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned positive. In 67 of the 81 cases, the stock moved higher in the following days. The odds of a move higher are at 83%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PATH's RSI Oscillator exited the oversold zone, 23 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for PATH just turned positive on October 05, 2026. Looking at past instances where PATH's MACD turned positive, the stock continued to rise in 32 of 44 cases over the following month. The odds of a continued upward trend are 73%.
Following a +4.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where PATH advanced for three days, in 236 of 299 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 53 of 60 cases where PATH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 88%.
The 10-day moving average for PATH crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 72%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PATH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for PATH entered a downward trend on October 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. PATH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.667) is normal, around the industry mean (15.930). P/E Ratio (20.463) is within average values for comparable stocks, (56.422). Projected Growth (PEG Ratio) (0.447) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.209) among similar stocks. P/S Ratio (4.248) is also within normal values, averaging (103.889).
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PATH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry ComputerCommunications
Advertisement